Page last updated: 2024-11-12

gilvocarcin v

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gilvocarcin V: from Actinomycete DO-38; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11027418
CHEMBL ID5174285
MeSH IDM0099627

Synonyms (4)

Synonym
gilvocarcin v
77879-90-4
4-[(2r,3r,4r,5s)-3,4-dihydroxy-5-[(1r)-1-hydroxyethyl]oxolan-2-yl]-8-ethenyl-1-hydroxy-10,12-dimethoxynaphtho[1,2-c]isochromen-6-one
CHEMBL5174285

Research Excerpts

Overview

Gilvocarcin V (GV) is an antitumor antibiotic with a coumarin-based aromatic structure. It promotes protein-DNA cross-linking when photoactivated by near-UV light.

ExcerptReferenceRelevance
"Gilvocarcin V (GV) is an antitumor antibiotic with a coumarin-based aromatic structure that promotes protein-DNA cross-linking when photoactivated by near-UV light. "( Histone H3 and heat shock protein GRP78 are selectively cross-linked to DNA by photoactivated gilvocarcin V in human fibroblasts.
Hanawalt, PC; Matsumoto, A, 2000
)
1.97
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1875262Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300 by broth microdilution method2022Journal of natural products, 10-28, Volume: 85, Issue:10
Antibacterial Gilvocarcin-Type Aryl-
AID1875261Antibacterial activity against Staphylococcus aureus ATCC 6538 by broth microdilution method2022Journal of natural products, 10-28, Volume: 85, Issue:10
Antibacterial Gilvocarcin-Type Aryl-
AID1875264Antibacterial activity against Escherichia coli ATCC 11775 by broth microdilution method2022Journal of natural products, 10-28, Volume: 85, Issue:10
Antibacterial Gilvocarcin-Type Aryl-
AID1875265Antibacterial activity against Candida albicans ATCC 10231 by broth microdilution method2022Journal of natural products, 10-28, Volume: 85, Issue:10
Antibacterial Gilvocarcin-Type Aryl-
AID1875266Antibacterial activity against Candida Candida glabrata ATCC 2001 by broth microdilution method2022Journal of natural products, 10-28, Volume: 85, Issue:10
Antibacterial Gilvocarcin-Type Aryl-
AID1875263Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 by broth microdilution method2022Journal of natural products, 10-28, Volume: 85, Issue:10
Antibacterial Gilvocarcin-Type Aryl-
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (36.96)18.7374
1990's12 (26.09)18.2507
2000's9 (19.57)29.6817
2010's7 (15.22)24.3611
2020's1 (2.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.53 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (93.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]